Clinical Trial – Friday Pop Quiz 6/5
The patient developed this cutaneous adverse event 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?
A. Epidermal growth factor receptor (EGFR) inhibitor
B. Tumor necrosis factor (TNF)-alpha inhibitor
C. Smoothened inhibitor
D. BRAF inhibitor
E. Programmed cell death (PD)-1 inhibitor
To find out the correct answer and …
![clinical trial](https://nextstepsinderm.com/wp-content/uploads/2020/06/04d477f22c16e2b4ce65ccd9dca5a8c3-small-2.jpg)
![clinical trial](https://nextstepsinderm.com/wp-content/uploads/2020/06/04d477f22c16e2b4ce65ccd9dca5a8c3-small-2.jpg)